S

Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294

Watchlist Manager
Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
Watchlist
Price: 31.15 CNY -0.1%
Market Cap: 34.7B CNY
Have any thoughts about
Shenzhen Salubris Pharmaceuticals Co Ltd?
Write Note

Shenzhen Salubris Pharmaceuticals Co Ltd
Accumulated Depreciation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shenzhen Salubris Pharmaceuticals Co Ltd
Accumulated Depreciation Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors

Company Accumulated Depreciation CAGR 3Y CAGR 5Y CAGR 10Y
S
Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
Accumulated Depreciation
-ÂĄ1.1B
CAGR 3-Years
-13%
CAGR 5-Years
-15%
CAGR 10-Years
-21%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Accumulated Depreciation
-ÂĄ2B
CAGR 3-Years
-20%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Accumulated Depreciation
-ÂĄ544m
CAGR 3-Years
-14%
CAGR 5-Years
-14%
CAGR 10-Years
-12%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Accumulated Depreciation
-ÂĄ4.7B
CAGR 3-Years
-14%
CAGR 5-Years
-15%
CAGR 10-Years
-18%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Accumulated Depreciation
-ÂĄ2.1B
CAGR 3-Years
-17%
CAGR 5-Years
-15%
CAGR 10-Years
-15%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Accumulated Depreciation
-ÂĄ495.5m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Shenzhen Salubris Pharmaceuticals Co Ltd's Accumulated Depreciation?
Accumulated Depreciation
-1.1B CNY

Based on the financial report for Jun 30, 2024, Shenzhen Salubris Pharmaceuticals Co Ltd's Accumulated Depreciation amounts to -1.1B CNY.

What is Shenzhen Salubris Pharmaceuticals Co Ltd's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 10Y
-21%

Over the last year, the Accumulated Depreciation growth was -11%. The average annual Accumulated Depreciation growth rates for Shenzhen Salubris Pharmaceuticals Co Ltd have been -13% over the past three years , -15% over the past five years , and -21% over the past ten years .

Back to Top